Retroviral marking and transplantation of rhesus hematopoietic cells by nonmyeloablative conditioning

Human Gene Therapy

Volumn 10, Issue 11, 1999, Pages 1783-1790

  Huhn, R D ^a   Tisdale, J F ^a   Agricola, B ^a   Metzger, M E ^a   Donahue, R E ^a   Dunbar, C E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 3; INTERLEUKIN 6; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3; RECOMBINANT INTERLEUKIN 6; RECOMBINANT STEM CELL FACTOR; STEM CELL FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CONDITIONING; CRYOPRESERVATION; DRUG EFFECT; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IRRADIATION; LEUKOCYTE COUNT; MARKER GENE; NONHUMAN; RHESUS MONKEY; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, CD34; DRUG RESISTANCE; GENE TRANSFER TECHNIQUES; GENETIC MARKERS; GENETIC VECTORS; GRAFT SURVIVAL; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; LEUKOCYTES, MONONUCLEAR; MACACA MULATTA; NEOMYCIN; POLYMERASE CHAIN REACTION; RADIATION DOSAGE; RETROVIRIDAE; STEM CELL FACTOR; TRANSDUCTION, GENETIC; TRANSPLANTATION CONDITIONING;

ANIMALIA; MACACA MULATTA; PRIMATES;

EID: 0033587487     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017464     Document Type: Article

References (41)

1. ANDREWS, R.G., BRIDDELL, R.A., KNITTER, G.H., ROWLEY, S.D., APPELBAUM, F.R., and McNIECE, I.K. (1995). Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates. Blood 85, 15-20.
2. BHATIA, M., BONNET, D., KAPP, U., WANG, J.C., MURDOCH, B., and DICK, J.E. (1997). Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J. Exp. Med. 18, 619-624.
3. BLOMBERG, M., RAO, S., REILLY, J., TIARKS, C., PETERS, S., KITTLER, E., and QUESENBERRY, P. (1998). Repetitive bone marrow transplantation in nonmyeloablated recipients. Exp. Hematol. 26, 320-324.
4. BODINE, D.M., SEIDEL, N.E., and ORLIC, D. (1996). Bone marrow collected 14 days after in vivo administration of granulocyte colony stimulating factor (G-CSF) and stem cell factor (SCF) to mice has 10 fold more repopulating ability than untreated bone marrow. Blood 88, 89-97.
5. BRENNER, M.K., RILL, D.R., HOLLADAY, M.S., HESLOP, H.E., MOEN, R.C., BUSCHLE, M., KRANCE, R.A., SANTANA, V.M., ANDERSON, W.F., and IHLE, J.N. (1993). Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342, 1134-1137.
6. CARTER, R.F., ABRAMS-OGG, A.C.G., DICK, J.E., KRUTH, S.A., VALLI, V.E., KAMEL-REID, S., and DUBE, I.D. (1992). Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood 79, 356-364.
7. CASSEL, A., COTTLER-FOX, M., DOREN, S., and DUNBAR, C.E. (1993). Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells. Exp. Hematol. 21, 585-591.
8. DAO, M.A., HANNUM, C.H., KOHN, D.B., and NOLTA, J.A. (1997). FLT3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction. Blood 89, 446-456.
9. DAO, M.A., SHAH, A.J., CROOKS, G.M., and NOLTA, J.A. (1998). Engraftment and retroviral marking of CD34+ and CD34+ CD38-human hematopoietic progenitors assessed in immune-deficient mice. Blood 91, 1243-1255.
10. DONAHUE, R.E., KIRBY, M.R., METZGER, M.E., AGRICOLA, B.A., SELLERS, S.E., and CULLIS, H.M. (1996). Peripheral blood CD34+ cells differ from bone marrow CD34+ cells in Thy-1 expression and cell cycle status in nonhuman primates mobilized or nonmobilized with granulocyte colony-stimulating factor and/or stem cell factor. Blood 87, 1644-1653.
11. DUNBAR, C.E. (1996). Gene transfer to hematopoietic stem cells: Implications for gene therapy of human disease. Annu. Rev. Med. 47, 11-20.
12. DUNBAR, C.E., and YOUNG, N.S. (1996). Gene marking and gene therapy directed at primary hematopoietic cells. Curr. Opin. Hematol. 3, 430-437.
13. DUNBAR, C.E., COTTLER-FOX, M., O'SHAUGHNESSY, J., DOREN, S., CARTER, C.S., BERENSON, R., BROWN, S., MOEN, R.C., GREENBLATT, J., STEWART, F.M., LEITMAN, S.F., WILSON, W., COWAN, K.H., YOUNG, N.S., and NIENHUIS, A.W. (1995). Retrovirally-marked CD34-enriched peripheral blood and bone marrow and cells contribute to long-term engraftment after autologous transplantation. Blood 85, 3048-3057.
14. DUNBAR, C.E., SEIDEL, N.B., DOREN, S., SELLERS, S., CLINE, A.P., METZGER, M.E., AGRICOLA, B.A., DONAHUE, R.E., and BODINE, D.M. (1996). Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor. Proc. Natl. Acad. Sci. U.S.A. 93, 11871-11876.
15. DUNBAR, C.E., KOHN, D.B., SCHIFFMAN, R., BARTON, N.W., NOLTA, J.A., ESPLIN, J.A., PENSIERO, M., LONG, Z., LOCKEY, C., EMMONS, R.V.B., CSIK, S., LEITMAN, S., KREBS, C.B., CARTER, C., BRADY, R.O., and KARLSSON, S. (1998). Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: In vivo detection of transduced cells without myeloablation. Hum. Gene Ther. 9, 2629-2640.
16. EMERSON, S.G. (1996). Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: The next generation of cellular therapeutics. Blood 87, 3082-3088.
17. EMMONS, R.V., DOREN, S., ZUJEWSKI, J., COTTLER-FOX, M., CARTER, C.S., HINES, K., O'SHAUGHNESSY, J.A., LEITMAN, S.F., GREENBLATT, J.J., COWAN, K., and DUNBAR, C.E. (1997). Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo. Blood 89, 4040-4046.
18. GOTHOT, A., VAN DER LOO, J.C.M., CLAPP, D.W., and SROUR, E.F. (1998). Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34+ cells in non-obese diabetic/severe combined immune-deficient mice. Blood 92, 2641-2649.
19. HANENBERG, H., HASHINO, K., KONISHI, H., HOCK, R.A., KATO, I., and WILLIAMS, D.A. (1997). Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells. Hum. Gene Ther. 10, 2193-2206.
20. HIRAYAMA, F., CLARK, S., and OGAWA, M. (1994). Negative regulation of early B lymphopoiesis by interleukin 3 and interleukin 1α. Proc. Natl. Acad. Sci. U.S.A. 91, 469.
21. KAPLITT, M.G., LEONE, P., SAMULSKI, R.J., XIAO, X., PFAFF, D.W., O'MALLEY, K.L., and DURING, M.J. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8, 148-154.
22. KIEM, H.P., ANDREWS, R.G., MORRIS, J., PETERSON, L., HEYWARD, S., ALLEN, J.M., RASKO, J.E.J., POTTER, J., and MILLER, A.D. (1998). Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, FLT-3 ligand, and megakaryocyte growth and development factor. Blood 92, 1878-1886.
23. KIM, H.J., OKAMOTO, Y., ITO, M., TAKAUE, Y., KAWANO, Y., WATANABE, T., YAMAUE, T., TOHDA, Y., OGOSE, T., and SHIMADA, T. (1997). Evaluation of a cytokine combination including thrombopoietin for improved transduction of a retroviral gene into G-CSF-mobilized CD34+ human blood cells. Stem Cells 15, 347-353.
24. KOHN, D.B., WEINBERG, K.I., NOLTA, J.A., HEISS, L.N., LENARSKY, C., CROOKS, G.M., HANLEY, M.E., ANNETT, G., BROOKS, J.S., EL-KHOUREIY, A., LAWRENCE, K., WELLS, S., MOEN, R.C., BASTIAN, J., WILLIAMS-HERMAN, D.E., ELDER, M., WARA, D., BOWEN, T., HERSHFIELD, M.S., MULLEN, C.A., BLAESE, R.M., and PARKMAN, R. (1995). Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency. Nature Med. 1, 1017-1023.
25. KOHN, D.B., HERSHFIELD, M.S., CARBONARO, D., SHIGEOKA, A., BROOKS, J., SMOGORZEWSKA, E.M., BARSKY, L.W., CHAN, R., BUROTITO, F., ANNETT, G., NOLTA, J.A., CROOKS, G., KAPOOR, N., ELDER, M., WARA, D., BOWEN, T., MADSEN, E., SNYDER, F.F., BASTIAN, J., MUUL, L., BLAESE, R.M., WEINBERG, K., and PARKMAN, M. (1998). T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates. Nature Med. 4, 775-780.
26. MACVITTIE, T.J., FARESE, A.M., PATCHEN, M.L., and MYERS, L.A. (1994). Therapeutic efficacy of recombinant interleukin-6 (IL-6) alone and combined with recombinant human IL-3 in a nonhuman primate model of high-dose, sublethal radiation-induced marrow aplasia. Blood 84, 2515-2522.
27. MALECH, H., MAPLES, P.B., WHITING-THEOBALD, N., LINTON, G.F., SEKHSARIA, S., VOWELLS, S.J., LI, F., MILLER, J.A., DECARLO, E., HOLLAND, S.M., LEITMAN, S.F., CARTER, C.S., BUTZ, R., READ, E.J., FLEISHER, T.A., SCHNEIDERMAN, R.D., VAN EPPS, D.E., SPRATT, S.K., MAACK, C.A., ROKOVICH, J.A., COHEN, L.K., and GALLIN, J.I. (1997a). Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease. Proc. Natl. Acad. Sci. U.S.A. 94, 12133-12138.
28. MALECH, H.L., BAUER, T.R., and HICKSTEIN, D.D. (1997b). Prospects for gene therapy of neutrophil defects. Semin. Hematol. 34, 355-361.
29. MARDINEY, M., III, and MALECH, H.L. (1996). Enhanced engraftment of hematopoietic progenitor cells in mice treated with granulocyte colony-stimulating factor before low-dose irradiation: Implications for gene therapy. Blood 87, 4049-4056.
30. MARDINEY, M., III, JACKSON, S.H., SPRATT, S.K., LI, F., HOLLAND, S.M., and MALECH, H.L. (1997). Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease. Blood 89, 2268-2275.
31. MATSUNAGA, T., HIRAYAMA, F., YONEMURA, Y., MURRAY, R., and OGAWA, M. (1998). Negative regulation by interleukin-3 (IL-3) of mouse early B-cell progenitors and stem cells in culture: Transduction of the negative signals by beta-c and beta-IL-3 receptor and absence of negative regulation by granulocyte-macrophage colony-stimulating factor. Blood 92, 901-907.
32. MILLER, A.D., and BUTTIMORE, C. (1986). Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6, 2895-2902.
33. PETERS, S.O., KITTLER, E.L.W., RAMSHAW, H.S., and QUESENBERRY, P.J. (1995). Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp. Hematol. 23, 461-466.
34. RAO, S.S., PETERS, S.O., CRITTENDEN, R.B., STEWART, F.M., RAMSHAW, H.S., and QUESENBERRY, P.J. (1997). Stem cell transplantation in the normal nonmyeloablated host: Relationship between cell dose, schedule, and engraftment. Exp. Hematol. 25, 114-121.
35. REBEL, V.I., TANAKA, M., LEE, J.-S., HARTNETT, S., PULSIPHER, M., NATHAN, D.G., MULLIGAN, R.C., and SIEFF, C.A. (1999). One-day ex vivo culture allows effective gene transfer into human nonobese diabetic/severe combined immune-deficient repopulating cells using high-titer vescicular stomatitis virus G protein pseudotyped retrovirus. Blood 93, 2217-2224.
36. SCHIFFMAN, R., MEDIN, J.A., WARD, J.M., STAHL, S., COTTLER-FOX, M., and KARLSSON, S. (1995). Transfer of the human glucocerebrosidase gene into hematopoietic stem cells of nonablated recipients: Successful engraftment and long-term expression of the transgene. Blood 86, 1218-1227.
37. STEWART, F.M., CRITTENDEN, R.B., LOWRY, P.A., PEARSON-WHITE, S., and QUESENBERRY, P.J. (1993). Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 81, 2566-2571.
38. TISDALE, J.F., SELLERS, S.E., AGRICOLA, B.A., DONAHUE, R.E., and DUNBAR, C.E. (1998). Gene marking studies indicate that ex-vivo expansion of mobilized rhesus peripheral blood cells results in rapid initial engraftment but diminished long term repopulating ability. Blood 92, 1131-1141.
39. VAN BEUSECHEM, V.W., and VALERIO, D. (1996). Gene transfer into hematopoietic stem cells of nonhuman primates. Hum. Gene Ther. 7, 1649-1668.
40. WU, D., and KEATING, A. (1993). Hematopoietic stem cells engraft in untreated transplant recipients. Exp. Hematol. 21, 251-256.
41. YONEMURA, Y., KU, H., HIRAYAMA, F., SOUZA, L.M., and OGAWA, M. (1996). Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc. Natl. Acad. Sci. U.S.A. 93, 4040-4044.